These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1533 related items for PubMed ID: 27370781
1. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Descamps G, Karaca Y, Lechien JR, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S. J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781 [Abstract] [Full Text] [Related]
2. Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas. Duray A, Descamps G, Decaestecker C, Sirtaine N, Gilles A, Khalifé M, Chantrain G, Depuydt CE, Delvenne P, Saussez S. Oncol Rep; 2013 Jul; 30(1):371-6. PubMed ID: 23603900 [Abstract] [Full Text] [Related]
4. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Linge A, Schötz U, Löck S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M, DKTK-ROG. Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747 [Abstract] [Full Text] [Related]
5. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. J Natl Cancer Inst; 2000 May 03; 92(9):709-20. PubMed ID: 10793107 [Abstract] [Full Text] [Related]
10. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. López RV, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DL, Saggioro FP, de Carvalho MB, Kowalski LP, Abrahão M, de Góis-Filho F, Tajara EH, Waterboer T, Boffetta P, Brennan P, Wünsch-Filho V. Cancer Causes Control; 2014 Apr 03; 25(4):461-71. PubMed ID: 24474236 [Abstract] [Full Text] [Related]
15. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. J Natl Cancer Inst; 2008 Feb 20; 100(4):261-9. PubMed ID: 18270337 [Abstract] [Full Text] [Related]
16. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Rosenthal DI, Harari PM, Giralt J, Bell D, Raben D, Liu J, Schulten J, Ang KK, Bonner JA. J Clin Oncol; 2016 Apr 20; 34(12):1300-8. PubMed ID: 26712222 [Abstract] [Full Text] [Related]